[Automatic translation follows] Accelerate research and innovation in oncology
The Cancéropôle Nord-Ouest (CNO), born from the Cancer Plan 1 in 2003, mobilizes an interregion which brings together Hauts-de-France and Normandy to combat cancer. It corresponds to a population pool of nearly 10 million inhabitants (17% of the French population), who are more often affected and die more than elsewhere in France from cancer. This interregion has a potential bringing together nearly 63 certified research teams (INSERM, CNRS, Universities) collaborating with 49 clinical services and hospital laboratories around the unifying term “From tumor screening to therapeutic innovation”. Since August 28, 2008, the Cancéropôle Nord-Ouest has been a Public Interest Group (GIP) created for 9 years by 13 founding members from the North-West region: 4 universities, 4 university hospital centers (CHU), 3 centers of the fight against cancer (CLCC), INSERM and CNRS.
Animation and promotion of research, Detection and emergence of innovative projects and structuring actions, new technologies, Stimulation of clinical research, Support for researchers, and Research on inequalities in cancer
Accélérer la recherche et l'innovation en cancérologie
Le Cancéropôle Nord-Ouest (CNO), né du Plan Cancer 1 en 2003, mobilise contre le cancer une interrégion qui regroupe les Hauts-de-France et la Normandie. Elle correspond à un bassin de population de près de 10 millions d'habitants (17% de la population française), qui sont plus souvent frappés et meurent davantage qu'ailleurs en France du cancer. Cette interrégion dispose d'un potentiel regroupant près de 63 équipes de recherche labellisées (INSERM, CNRS, Universités) collaborant avec 49 services cliniques et laboratoires hospitaliers autour du terme fédérateur "Du dépistage des tumeurs à l'innovation thérapeutique". Le Cancéropôle Nord-Ouest est depuis le 28 août 2008 un Groupement d'Intérêt Public (GIP) créé pour 9 ans par 13 membres fondateurs issus de l'interrégion Nord-Ouest: 4 universités, 4 centres hospitaliers universitaires (CHU), 3 centres de lutte contre le cancer (CLCC), l'INSERM et le CNRS.
Animation et valorisation de la recherche, Détection et émergence de projets innovants et d'actions structurantes, de nouvelles technologies, Stimulation de la recherche clinique, Accompagnement des chercheurs, and Recherche sur les inégalités face au cancer
Canceropôle Nord-Ouest est l'un des 7 canceropôles créés dans le cadre du plan cancer. Recherche et projets contre le cancer.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Other 23 May 2018 23 Feb 2024 | | |
MSD Pharmaceutical, Pharmaceutical Manufacturing | MSD Pharmaceutical, Pharmaceutical Manufacturing | Other 24 May 2018 | | |
Université Paris-Saclay Research, Higher Education | Université Paris-Saclay Research, Higher Education | Other 15 May 2019 | | |
Institut Curie Health, Hospitals and Health Care | Institut Curie Health, Hospitals and Health Care | Other 18 Feb 2022 23 Feb 2024 | | |
MoHo Think Tanks | MoHo Think Tanks | Other 8 Dec 2022 | | |
Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 23 Feb 2024 | | |
Gustave Roussy Health, Hospitals and Health Care | Gustave Roussy Health, Hospitals and Health Care | Other 23 Feb 2024 | | |
CNRS Innovation Research, Research Services | CNRS Innovation Research, Research Services | Other 23 Feb 2024 | | |
Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 23 Feb 2024 | | |
BioValley France Public business cluster, Biotechnology, French Cluster, Biotechnology Research | BioValley France Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 23 Feb 2024 | |